Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance
Apr 13, 2016 ·
2m 19s
Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
